ArticleFrontiers in genetics2022

Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity.

Zhaohui Ruan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.